10亿交易与一个时代的终结:上海医药清仓中美施贵宝

Ofweek维科网
Feb 26

2026年立春,上海医药集团股份有限公司的一纸公告,为一家拥有44年历史的老牌合资药企画上了句号。公告显示,上海医药拟通过产权交易所公开挂牌转让所持中美上海施贵宝制药有限公司30%股权,挂牌底价不低于10.23亿元。交易完成后,上海医药将不再持有中美施贵宝任何股份。这不仅是10.23亿元的资产变现,更是一个时代的终章。然而,就在这份清仓公告发布的同一时间,上海医药自己正站在十字路口。毛利率连续五年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10